InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery

News   Nov 18, 2008

 
InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery
 
 
 
 

RELATED ARTICLES

Understanding the Cellular Systems that Hold Back the Spread of Cancer

News

Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

READ MORE

Ingestible Drug-Delivery Materials May Improve Patient Treatment Compliance

News

Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.

READ MORE

Researchers Develop New Method to Generate Human Antibodies

News

Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE